About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

United States FDA Approves Diabetes Drug Jardiance to Reduce Cardiovascular Disease

by Dr. Trupti Shirole on December 4, 2016 at 11:28 PM
Font : A-A+

 United States FDA Approves Diabetes Drug Jardiance to Reduce Cardiovascular Disease

Death from cardiovascular disease is 70% higher in adults with diabetes compared to those without diabetes, and patients with diabetes have a decreased life expectancy driven in large part by premature cardiovascular death, suggests the US Centers for Disease Control and Prevention.

Jardiance, a prescription medicine used along with diet and exercise to lower blood sugar, can now be prescribed to reduce the risk of cardiovascular death in adult patients with Type-2 diabetes and cardiovascular disease, the US Food and Drug Administration (FDA) has ruled.

Advertisement


"Cardiovascular disease is a leading cause of death in adults with Type-2 diabetes mellitus," Jean-Marc Guettier from FDA's Center for Drug Evaluation and Research said. "Availability of antidiabetes therapies that can help people live longer by reducing the risk of cardiovascular death is an important advance for adults with Type-2 diabetes," Guettier said.

The FDA's decision is based on a postmarketing study required by the agency when it approved Jardiance in 2014 as an adjunct to diet and exercise to improve glycemic control in adults with Type-2 diabetes mellitus.
Advertisement

Jardiance, also known as empagliflozin, was studied in a postmarket clinical trial of more than 7,000 patients with Type-2 diabetes and cardiovascular disease.

In the trial, Jardiance was shown to reduce the risk of cardiovascular death compared to a placebo when added to standard of care therapies for diabetes and atherosclerotic cardiovascular disease.

The most common side effects of Jardiance, distributed by Boehringer Ingelheim Pharmaceuticals, are urinary tract infections and female genital infections.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity Stress Relief Through Alternative Medicine 

Most Popular on Medindia

Color Blindness Calculator Drug Side Effects Calculator Post-Nasal Drip A-Z Drug Brands in India Indian Medical Journals Vent Forte (Theophylline) The Essence of Yoga Find a Hospital Turmeric Powder - Health Benefits, Uses & Side Effects Hearing Loss Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR

×

United States FDA Approves Diabetes Drug Jardiance to Reduce Cardiovascular Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests